​

Hyperion DeFi Stock (NASDAQ:HYPD)

RevenueOwnershipFinancialsChartTranscripts
Hyperion DeFi by TradingView

Previous Close

$3.90

52W Range

$1.40 - $17.18

50D Avg

$3.70

200D Avg

$5.17

Market Cap

$18.07M

Avg Vol (3M)

$434.10K

Beta

2.58

Div Yield

-

HYPD Company Profile

A U.S.-based firm pivoting from ophthalmic drug-delivery tech (Optejet) to becoming the first Nasdaq-listed U.S. company with a cryptocurrency treasury denominated in HYPE tokens from the Hyperliquid blockchain; also operates a validator (“Kinetiq × Hyperion”) and continues DeFi staking strategies alongside ongoing development of Optejet UFD™ for eye care.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

13

IPO Date

Jul 02, 2025

Website

HYPD Performance

HYPD Financial Summary

Dec 24Dec 23Dec 22
Revenue$57.34K$3.79K-
Operating Income$-48.74M$-25.41M$-26.91M
Net Income$-49.82M$-27.26M$-28.01M
EBITDA$-46.21M$-24.11M$-26.32M
Basic EPS$-59.81$-53.15$-66.40
Diluted EPS$-59.81$-53.15$-66.40

Fiscal year ends in Dec 24 | Currency in USD

Latest Earnings Call Transcripts

Q1 26May 14, 26 | 12:00 AM
Q3 25Nov 14, 25 | 5:00 PM

Peer Comparison

TickerCompany
PIIIP3 Health Partners Inc.
MURAMural Oncology plc
NMTCNeuroOne Medical Technologies Corporation
JSPRJasper Therapeutics, Inc.
BTAIBioXcel Therapeutics, Inc.
VRCAVerrica Pharmaceuticals Inc.
MODDModular Medical, Inc.
ECORelectroCore, Inc.
RBOTVicarious Surgical Inc.